ArticleBMC cancer2025

Development and validation of a predictive model for recurrence in postoperative patients with stage ⅠA1-ⅢA non-small cell lung cancer.

Yi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.